Clinical trial · Interventional
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid thermal ablation. The procedure uses local anesthesia, so participants remain awake and may feel tense. Human-centered care focuses on emotional support, clear communication, comfort, and follow-up, and it may improve the experience and recovery for patients. The main questions are: Does human-centered nursing care reduce emotional distress levels in patients undergoing thyroid thermal ablation? Does human-centered nursing care improve patient quality of life after thyroid thermal ablation? If there is a comparison group: Researchers will compare human-centered nursing care to usual nursing care to see if human-centered care leads to lower emotional distress and higher quality of life. Participants will: Receive either human-centered nursing care or usual nursing care. Complete questionnaires before, during, and after the procedure to measure emotional distress, quality of life, pain, and satisfaction with care. Have their vital signs and quality of life tracked during and after the procedure. Have their adherence to care plans and any complications monitored. The main outcomes are emotional distress levels and quality of life. Other outcomes include pain and vital signs during the procedure, satisfaction with care, and complication rates. Results may guide better care for people undergoing small, minimally invasive treatments while awake.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Papillary Thyroid Carcinoma | Thyroid Gland Papillary Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Humanistic Continuing Care via WeChat | Behavioral | — | UNRESOLVED |
| Usual Care (No Structured WeChat Program) | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Humanistic Continuing Care via WeChat
- interventionNames
- Behavioral: Humanistic Continuing Care via WeChat
- type
- ACTIVE_COMPARATOR
- label
- Usual Care (No Structured WeChat Program)
- interventionNames
- Procedure: Usual Care (No Structured WeChat Program)
Primary outcomes (3)
- measure
- Change in emotion distress from baseline to post-procedure (HADS)
- timeFrame
- From enrollment to the end of treatment at 3 months
- measure
- Change in the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scores from baseline to 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Age 16-60 years; scheduled for thyroid thermal ablation * Papillary thyroid carcinoma (PTC) * Number of target lesions \<= 3 * Largest lesion diameter \<= 2 cm; clinical stage T1N0M0 by imaging * Awake and able to cooperate under local anesthesia Owns a smartphone and can use WeChat Exclusion Criteria: * Serious medical comorbidities or cognitive impairment that precludes participation * Prior thyroid surgery or thermal ablation * Unwilling or unable to join the WeChat group or complete postoperative follow-up
References
Publications (0)
Data not yet available